Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia.

MLA

Reginster, Jean-Yves, et al. “Recommendations for the Conduct of Clinical Trials for Drugs to Treat or Prevent Sarcopenia.” Aging Clinical and Experimental Research, vol. 28, no. 1, Feb. 2016, pp. 47–58. EBSCOhost, https://doi.org/10.1007/s40520-015-0517-y.

APA

Reginster, J.-Y., Cooper, C., Rizzoli, R., Kanis, J. A., Appelboom, G., Bautmans, I., Bischoff-Ferrari, H. A., Boers, M., Brandi, M. L., Bruyère, O., Cherubini, A., Flamion, B., Fielding, R. A., Gasparik, A. I., Van Loon, L., McCloskey, E., Mitlak, B. H., Pilotto, A., Reiter-Niesert, S., … Cruz-Jentoft, A. J. (2016). Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clinical and Experimental Research, 28(1), 47–58. https://doi.org/10.1007/s40520-015-0517-y

Chicago

Reginster, Jean-Yves, Cyrus Cooper, René Rizzoli, John A Kanis, Geoff Appelboom, Ivan Bautmans, Heike A Bischoff-Ferrari, et al. 2016. “Recommendations for the Conduct of Clinical Trials for Drugs to Treat or Prevent Sarcopenia.” Aging Clinical and Experimental Research 28 (1): 47–58. doi:10.1007/s40520-015-0517-y.